Drug Shortage Report for MYLAN-ABACAVIR/LAMIVUDINE

Last updated on 2019-02-16 History
Report ID 65420
Drug Identification Number 02450682
Brand name MYLAN-ABACAVIR/LAMIVUDINE
Common or Proper name ABACAVIR/LAMIVUDINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30BL
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2018-09-04
Actual start date 2018-09-04
Estimated end date 2019-02-15
Actual end date 2019-02-15
Shortage status Resolved
Updated date 2019-02-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-02-16 English Compare
v8 2019-02-15 French Compare
v7 2019-02-15 English Compare
v6 2019-01-30 French Compare
v5 2019-01-30 English Compare
v4 2018-11-20 French Compare
v3 2018-11-20 English Compare
v2 2018-10-23 French Compare
v1 2018-10-23 English Compare

Showing 1 to 9 of 9